Exide Industries Adds ₹100 Crore for Bengaluru Plant

Fresh rights issue investment

Exide Industries Limited has invested ₹99.99 crore in its wholly owned subsidiary, Exide Energy Solutions Limited (EESL), through a rights issue. The capital infusion was completed on September 29, 2026. It supports EESL's greenfield lithium-ion battery manufacturing project in Bengaluru. The transaction is part of Exide Industries' ongoing investment programme in domestic advanced battery manufacturing. EESL remains a 100% subsidiary after the allotment. Exide's cumulative investment in EESL has consequently risen to ₹5,202.23 crore. The amount includes investments in the erstwhile merged subsidiary Exide Energy Private Limited (EEPL). The company has said the funds will meet project and other funding requirements at EESL.

Share allotment details

Under the rights offering, Exide Industries subscribed to 2,85,71,428 equity shares of EESL. Each share had a face value of ₹10 and was issued at a premium of ₹25. The total issue price was therefore ₹35 per share. The subscription aggregated to ₹99.99 crore. As this was a rights-based subscription by the sole shareholder, it did not change Exide Industries' ownership in EESL. The subsidiary continues to be fully controlled by Exide Industries. The transaction is a related-party transaction because EESL is a wholly owned subsidiary. The available information states that the investment was made for EESL's funding requirements.

Funding is directed at Bengaluru facility

EESL is developing a greenfield manufacturing facility in Bengaluru. The facility is intended to make lithium-ion battery cells, modules and packs. Its targeted end markets include electric vehicles and stationary energy storage applications in India. Cell manufacturing is a central part of the planned project, alongside module and battery-pack production. The latest equity infusion adds to the financial resources being deployed for this facility. EESL was incorporated on March 24, 2022, to develop advanced battery manufacturing capabilities in India. The company is building the project as a multi-gigawatt lithium-ion cell manufacturing facility. Earlier disclosures described the project as a 12 GWh facility being developed in two phases.

Investment sequence during 2026

The September subscription follows several capital infusions into EESL during 2026. Exide invested ₹450 crore through a rights issue on March 25, 2026. That transaction took its total investment in EESL to ₹4,802.23 crore. EESL allotted 11.25 crore equity shares at a face value of ₹10 and a premium of ₹30 per share in that issue. Exide then invested ₹199.99 crore on August 18, 2026. It subscribed to 5,71,42,857 shares at ₹35 each, consisting of ₹10 face value and ₹25 premium. Following the August infusion, cumulative investment stood at ₹5,102.23 crore. The September investment of ₹99.99 crore has lifted that figure to ₹5,202.23 crore.

Key disclosed investment data

Board approval provides funding framework

On January 30, 2026, Exide Industries' board approved an additional investment of up to ₹1,400 crore in EESL. The approval allowed investment through equity subscriptions in one or more tranches. Its stated purpose was funding the development of the greenfield multi-gigawatt lithium-ion cell manufacturing facility. The March, August and September rights subscriptions were disclosed during the same year as the board approval. The approval gives Exide a framework to make additional equity infusions, subject to the stated limit and relevant corporate actions. The article information does not specify a schedule for completion of the facility. It also does not provide production commencement dates. Exide has consistently described the funding as support for EESL's project development and related needs.

What the investment means for Exide

The investment increases Exide Industries' capital committed to its lithium-ion battery business without diluting its ownership of EESL. Retaining 100% ownership means EESL remains fully consolidated within the parent company's operations. The funding is directed toward manufacturing infrastructure rather than an acquisition or external partnership. EESL's proposed product range addresses two identified application areas: electric vehicles and stationary storage. These segments require lithium-ion cells and related battery systems. The disclosed investments show that the Bengaluru project is being funded in multiple equity tranches. The September issue is smaller than the March and August infusions, but it takes the cumulative investment above ₹5,200 crore. No change in EESL's shareholding structure was reported.

Domestic battery manufacturing context

EESL's project is focused on producing cells, modules and packs in India. Battery cells are a key component of electric vehicle battery systems and stationary storage installations. Exide's stated plan places EESL in the domestic lithium-ion manufacturing segment rather than limiting the subsidiary to conventional battery operations. The Bengaluru facility is intended to serve India's EV market as well as stationary applications. The company has not provided financial projections, capacity utilisation figures or revenue forecasts in the information available. It has, however, identified the project as a multi-gigawatt facility and earlier disclosures referred to a 12 GWh plan in two phases. The scale of cumulative investment reflects the capital-intensive nature of setting up cell manufacturing operations. Further progress will depend on the company's subsequent project and funding disclosures.

Market impact and investor relevance

For investors, the immediate financial detail is the increase in Exide Industries' cumulative investment in EESL to ₹5,202.23 crore. The rights issue does not change the parent company's stake because EESL remains wholly owned. There is therefore no dilution of Exide's interest in the subsidiary from this transaction. The infusion adds equity funding for the Bengaluru plant and its associated requirements. The company has not disclosed a separate market-price reaction, earnings impact or revised financial guidance in the provided information. Nor has it disclosed project commissioning dates or commercial output targets alongside the September transaction. Investors will likely track future equity subscriptions under the board-approved investment framework and updates on the greenfield facility. Any assessment of returns from the project will require operating and financial disclosures after the facility advances further.

Next steps for the battery subsidiary

The latest transaction continues Exide Industries' stated plan to fund EESL's lithium-ion manufacturing build-out. The company has already made investments in several tranches during 2026. EESL will use the capital for its Bengaluru greenfield project and other funding requirements associated with establishing its operations. Its planned products include lithium-ion cells, modules and packs for EV and stationary storage uses. Exide's ownership remains at 100%, preserving its full interest in the subsidiary's future operations. The board's January approval permits further equity investment of up to ₹1,400 crore through one or more tranches. Future company filings will be important for details on additional funding, construction progress and manufacturing timelines. For now, the September rights issue takes Exide's disclosed cumulative investment in EESL to ₹5,202.23 crore.